Special Issue "State-of-the-Art Nanomedicine and Nanobiotechnology in Europe"

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".

Deadline for manuscript submissions: 31 December 2023 | Viewed by 1994

Special Issue Editors

Physics Centre of Minho and Porto Universities (CF-UM-UP), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
Interests: drug delivery systems; magnetic and plasmonic nanoparticles; (magneto)liposomes; bionanomaterials; combined cancer therapy
Special Issues, Collections and Topics in MDPI journals
Physics Centre of Minho and Porto Universities (CF-UM-UP), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
Interests: drug delivery systems; biomaterials; nanomaterials; colloids and interfaces; nanomedicine; nanosystems for theranostics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Several advances in nanotechnology have been achieved in the past few years, overcoming major challenges underpinning the biotechnological and medical fields. Together with the development of novel materials, these fields have witnessed a paradigm shift in the strategies for various applications ranging from drug delivery and tissue engineering to biosensors and microfluidics. In addition, multifunctional smart nanomaterials are increasingly becoming a dominant means to achieve complex tasks in nanomedicine and nanobiotechnology.

This Special Issue aims to attract the academic and scientific communities within the nanomaterials field to contribute with developments on nanomedicine and nanobiotechnological applications. We hope this Special Issue will provide a collection of original articles and reviews addressing the current state-of-the-art in addition to innovative and cutting-edge research related to the principles, fabrication, safety and application of nanomaterials as well as the translation to clinical trials. The systems can include (but are not limited to) biomaterials, carbonaceous materials, metal-organic frameworks, magnetic and/or plasmonic materials.

We look forward to receiving your contributions

Dr. Elisabete M. S. Castanheira
Dr. Sérgio R. S. Veloso
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanomaterials
  • nanomedicine
  • nanobiotechnology
  • multifunctional materials
  • smart materials

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Magnetoliposomes Containing Multicore Nanoparticles and a New Antitumor Thienopyridine Compound with Potential Application in Chemo/Thermotherapy
Biomedicines 2022, 10(7), 1547; https://doi.org/10.3390/biomedicines10071547 - 29 Jun 2022
Cited by 5 | Viewed by 1601
Abstract
Multicore magnetic nanoparticles of manganese ferrite were prepared using carboxymethyl dextran as an agglutinating compound or by an innovative method using melamine as a cross-coupling agent. The nanoparticles prepared using melamine exhibited a flower-shape structure, a saturation magnetization of 6.16 emu/g and good [...] Read more.
Multicore magnetic nanoparticles of manganese ferrite were prepared using carboxymethyl dextran as an agglutinating compound or by an innovative method using melamine as a cross-coupling agent. The nanoparticles prepared using melamine exhibited a flower-shape structure, a saturation magnetization of 6.16 emu/g and good capabilities for magnetic hyperthermia, with a specific absorption rate (SAR) of 0.14 W/g. Magnetoliposome-like structures containing the multicore nanoparticles were prepared, and their bilayer structure was confirmed by FRET (Förster Resonance Energy Transfer) assays. The nanosystems exhibited sizes in the range of 250–400 nm and a low polydispersity index. A new antitumor thienopyridine derivative, 7-[4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl]thieno[3,2-b]pyridine, active against HeLa (cervical carcinoma), MCF-7 (breast adenocarcinoma), NCI-H460 (non-small-cell lung carcinoma) and HepG2 (hepatocellular carcinoma) cell lines, was loaded in these nanocarriers, obtaining a high encapsulation efficiency of 98 ± 2.6%. The results indicate that the new magnetoliposomes can be suitable for dual cancer therapy (combined magnetic hyperthermia and chemotherapy). Full article
(This article belongs to the Special Issue State-of-the-Art Nanomedicine and Nanobiotechnology in Europe)
Show Figures

Figure 1

Back to TopTop